Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Lifeway Foods ( (LWAY) ) just unveiled an update.
Lifeway Foods, a leader in probiotic kefir products, has rejected Danone’s $27 per share acquisition offer, deeming it undervalued. The company highlights its robust growth and strong financial performance, including a 788% shareholder return over five years and a projected EBITDA of $45-50 million by 2027. Lifeway’s board believes its standalone strategy offers superior value, driven by consumer interest in gut health and operational efficiencies.
See more data about LWAY stock on TipRanks’ Stock Analysis page.